Why Iambic Therapeutics, Inc. (IAM) stock rose 20.0% on Tuesday, November 17, 2026

Iambic Therapeutics, Inc. (IAM) closed at $14.22, up 20.00% on Tuesday, November 17, 2026, on volume of 479,694 shares (0.6× its 3-month average); market value about $700.0M, according to Nexqual market data (nexqual.com/moves/2026-11-17/IAM).

What happened: primary sources

Events Nexqual found for IAM on Tuesday, November 17, 2026 or the trading day before (November 16, 2026), each linked to its primary source:

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on IAM

IAM stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 17, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:31 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 18, 2026 at 20:31 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt